Selected research
Industry Research
Blister Pack Pharmaceutical Products Industry Research Report 2026
Market perspective
The global Blister Pack Pharmaceutical Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Blister Pack Pharmaceutical Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Blister Pack Pharmaceutical Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Blister Pack Pharmaceutical Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Blister Pack Pharmaceutical Products include Sun Pharmaceutical Industries Ltd, Sanofi, Johnson & Johnson, Novartis AG, Merck, Pfizer Inc, GlaxoSmithKline plc, Roche Holding AG and Cadila Healthcare, etc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Blister Pack Pharmaceutical Products market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Blister Pack Pharmaceutical Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blister Pack Pharmaceutical Products Market by Company
Sun Pharmaceutical Industries Ltd
Sanofi
Johnson & Johnson
Novartis AG
Merck
Pfizer Inc
GlaxoSmithKline plc
Roche Holding AG
Cadila Healthcare, etc.
Allergan
Blister Pack Pharmaceutical Products Segment by Type
Tablets
Capsules
Blister Pack Pharmaceutical Products Segment by Application
Veterinary Drugs
Pharmaceuticals
Nutraceuticals and Supplements
Blister Pack Pharmaceutical Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blister Pack Pharmaceutical Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blister Pack Pharmaceutical Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blister Pack Pharmaceutical Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blister Pack Pharmaceutical Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Veterinary Drugs
- Pharmaceuticals
- Nutraceuticals and Supplements
Companies covered
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Johnson & Johnson
- Novartis AG
- Merck
- Pfizer Inc
- GlaxoSmithKline plc
- Roche Holding AG
- Cadila Healthcare, etc.
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Blister Pack Pharmaceutical Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Tablets
- 2.2.3 Capsules
- 2.3 Blister Pack Pharmaceutical Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Veterinary Drugs
- 2.3.3 Pharmaceuticals
- 2.3.4 Nutraceuticals and Supplements
- 2.4 Assumptions and Limitations
3 Blister Pack Pharmaceutical Products Breakdown Data by Type
- 3.1 Global Blister Pack Pharmaceutical Products Historic Market Size by Type (2021-2026)
- 3.2 Global Blister Pack Pharmaceutical Products Forecasted Market Size by Type (2027-2032)
4 Blister Pack Pharmaceutical Products Breakdown Data by Application
- 4.1 Global Blister Pack Pharmaceutical Products Historic Market Size by Application (2021-2026)
- 4.2 Global Blister Pack Pharmaceutical Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Blister Pack Pharmaceutical Products Market Perspective (2021-2032)
- 5.2 Global Blister Pack Pharmaceutical Products Growth Trends by Region
- 5.2.1 Global Blister Pack Pharmaceutical Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Blister Pack Pharmaceutical Products Historic Market Size by Region (2021-2026)
- 5.2.3 Blister Pack Pharmaceutical Products Forecasted Market Size by Region (2027-2032)
- 5.3 Blister Pack Pharmaceutical Products Market Dynamics
- 5.3.1 Blister Pack Pharmaceutical Products Industry Trends
- 5.3.2 Blister Pack Pharmaceutical Products Market Drivers
- 5.3.3 Blister Pack Pharmaceutical Products Market Challenges
- 5.3.4 Blister Pack Pharmaceutical Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Blister Pack Pharmaceutical Products Players by Revenue
- 6.1.1 Global Top Blister Pack Pharmaceutical Products Players by Revenue (2021-2026)
- 6.1.2 Global Blister Pack Pharmaceutical Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Blister Pack Pharmaceutical Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blister Pack Pharmaceutical Products Head Office and Area Served
- 6.4 Global Blister Pack Pharmaceutical Products Players, Product Type & Application
- 6.5 Global Blister Pack Pharmaceutical Products Manufacturers Established Date
- 6.6 Global Blister Pack Pharmaceutical Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 7.2 North America Blister Pack Pharmaceutical Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 7.4 North America Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 8.2 Europe Blister Pack Pharmaceutical Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 8.4 Europe Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 9.2 Asia-Pacific Blister Pack Pharmaceutical Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 10.2 South America Blister Pack Pharmaceutical Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 10.4 South America Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Blister Pack Pharmaceutical Products Market Size (2021-2032)
- 11.2 Middle East & Africa Blister Pack Pharmaceutical Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Blister Pack Pharmaceutical Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sun Pharmaceutical Industries Ltd
- 12.1.1 Sun Pharmaceutical Industries Ltd Company Information
- 12.1.2 Sun Pharmaceutical Industries Ltd Business Overview
- 12.1.3 Sun Pharmaceutical Industries Ltd Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.1.4 Sun Pharmaceutical Industries Ltd Blister Pack Pharmaceutical Products Product Portfolio
- 12.1.5 Sun Pharmaceutical Industries Ltd Recent Developments
- 12.2 Sanofi
- 12.2.1 Sanofi Company Information
- 12.2.2 Sanofi Business Overview
- 12.2.3 Sanofi Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.2.4 Sanofi Blister Pack Pharmaceutical Products Product Portfolio
- 12.2.5 Sanofi Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.3.4 Johnson & Johnson Blister Pack Pharmaceutical Products Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Novartis AG
- 12.4.1 Novartis AG Company Information
- 12.4.2 Novartis AG Business Overview
- 12.4.3 Novartis AG Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.4.4 Novartis AG Blister Pack Pharmaceutical Products Product Portfolio
- 12.4.5 Novartis AG Recent Developments
- 12.5 Merck
- 12.5.1 Merck Company Information
- 12.5.2 Merck Business Overview
- 12.5.3 Merck Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.5.4 Merck Blister Pack Pharmaceutical Products Product Portfolio
- 12.5.5 Merck Recent Developments
- 12.6 Pfizer Inc
- 12.6.1 Pfizer Inc Company Information
- 12.6.2 Pfizer Inc Business Overview
- 12.6.3 Pfizer Inc Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.6.4 Pfizer Inc Blister Pack Pharmaceutical Products Product Portfolio
- 12.6.5 Pfizer Inc Recent Developments
- 12.7 GlaxoSmithKline plc
- 12.7.1 GlaxoSmithKline plc Company Information
- 12.7.2 GlaxoSmithKline plc Business Overview
- 12.7.3 GlaxoSmithKline plc Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.7.4 GlaxoSmithKline plc Blister Pack Pharmaceutical Products Product Portfolio
- 12.7.5 GlaxoSmithKline plc Recent Developments
- 12.8 Roche Holding AG
- 12.8.1 Roche Holding AG Company Information
- 12.8.2 Roche Holding AG Business Overview
- 12.8.3 Roche Holding AG Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.8.4 Roche Holding AG Blister Pack Pharmaceutical Products Product Portfolio
- 12.8.5 Roche Holding AG Recent Developments
- 12.9 Cadila Healthcare, etc.
- 12.9.1 Cadila Healthcare, etc. Company Information
- 12.9.2 Cadila Healthcare, etc. Business Overview
- 12.9.3 Cadila Healthcare, etc. Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.9.4 Cadila Healthcare, etc. Blister Pack Pharmaceutical Products Product Portfolio
- 12.9.5 Cadila Healthcare, etc. Recent Developments
- 12.10 Allergan
- 12.10.1 Allergan Company Information
- 12.10.2 Allergan Business Overview
- 12.10.3 Allergan Revenue in Blister Pack Pharmaceutical Products Business (2021-2026)
- 12.10.4 Allergan Blister Pack Pharmaceutical Products Product Portfolio
- 12.10.5 Allergan Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst